BioXcel Therapeutics Appoints June Bray to Board of Directors Former Allergan executive brings extensive global regulatory experience across multiple therapeutic areas March 01, 2021 07:00 ET | Source: BioXcel Therapeutics BioXcel Therapeutics New Haven, Connecticut, UNITED STATES NEW HAVEN, Conn., March 01, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the appointment of June Bray to its Board of Directors. Ms. Bray brings over forty years of extensive U.S. and global regulatory experience in the healthcare industry and most recently served as Senior Vice President, Global Regulatory Affairs and Medical Writing at Allergan.